Additional Medical Studies

Medical products for human use are not currently available from ACell but are expected to become available later in 2008. Register now to receive updates on clinical trials and release dates for our medical products.

Additional Tendon & Ligament Case Studies

Regulatory Compliance and ACell Vet™ Veterinary Medical Devices

All ACell Vet™ UBM products, regardless of form (sheet, granule, powder, gel) are medical devices and are manufactured in the United States under a Quality Management System that is based on the FDA’s Good Manufacturing Practices (21 CFR Part 820). Use of the ACell Vet UBM products in veterinary treatments according to the product instructions is fully compliant with U.S. FDA laws and regulations. Download the entire "Regulatory Compliance and ACell Vet™ Veterinary Medical Devices" PDF Document

Treatment for equine musculotendinous and ligamentous injuries using UBM

These competition horses put quite a lot of stress on their bodies, particularly the upper level horses. We are going to address some of those issues that they have today and how we handle them. Download the entire "Treatment for equine musculotendinous and ligamentous injuries using UBM" PDF Document

Overview of Procedures Used by Practicing Veterinarians for Percutaneous Injection of the ACell Vet™ Powder for Treatment of Equine Tendon and Ligament Injuries

This document is offered as a courtesy, and provides an overview of the general protocol utilized by one of the primary investigators of the efficacy of ACell Vet™ Powder for the treatment of equine tendon and ligament injuries. The actual treatment protocol utilized should be based on the assessment of each individual case by the attending veterinarian. Consequently, this document is provided for background and informational purposes only. Download the entire "Overview of Procedures" PDF File

Evaluation of the safety and efficacy of the ACell Vet™ UBM powder as a treatment for musculotendinous and/or ligamentous repair in equine patients

Horses with evidence of a focal/localized tendon or ligament leg injury, confirmed and documented with diagnostic ultrasound, were entered into this study. The types of lesions treated included Suspensory Ligament (Chronic Desmitis, Tear, Core Lesion), and Superficial Digital Flexor Tendon (Tear, Diffuse, Core Lesion). 29 horses were randomly placed in two groups and were evaluated by the attending veterinarian for a total of 12 weeks. Download the entire "Evaluation of the safety and efficacy of the ACell Vet™ UBM powder" PDF Document

Treatment of Tendon and Ligament Injuries with ACell Vet™ UBM Powder

The objective of this retrospective study was to assess the therapeutic value of ACell Vet™ Urinary Bladder Matrix Powder (UBM) for tissue regeneration and return to function in tendon and ligament injuries of the equine limb. Assessment of response was by review of lameness evaluation, physical characteristics of involved structures, and visible improvement of identified ultrasound lesions in affected structures. Download the entire "Treatment of Tendon and Ligament Injuries" PDF Document